News
Pharmaceutical manufacturer GlaxoSmithKline (GSK) announced that as of Jan. 1 it would no longer produce the asthma inhaler Flovent, one of the most popular preventive and maintenance treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback